TUNINETTI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 797
EU - Europa 320
AS - Asia 210
AF - Africa 8
SA - Sud America 4
OC - Oceania 3
Totale 1.342
Nazione #
US - Stati Uniti d'America 785
IT - Italia 123
IE - Irlanda 80
SG - Singapore 72
CN - Cina 65
SE - Svezia 34
ID - Indonesia 19
VN - Vietnam 19
DE - Germania 16
FR - Francia 16
HK - Hong Kong 11
CA - Canada 9
UA - Ucraina 8
KR - Corea 7
JP - Giappone 6
NG - Nigeria 6
FI - Finlandia 5
RO - Romania 5
RU - Federazione Russa 5
GB - Regno Unito 4
PL - Polonia 4
AU - Australia 3
BR - Brasile 3
LU - Lussemburgo 3
MX - Messico 3
PT - Portogallo 3
TR - Turchia 3
BE - Belgio 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
ES - Italia 2
HR - Croazia 2
IN - India 2
NL - Olanda 2
TW - Taiwan 2
AR - Argentina 1
DK - Danimarca 1
GR - Grecia 1
IR - Iran 1
KE - Kenya 1
MA - Marocco 1
MY - Malesia 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 1.342
Città #
Chandler 175
Dublin 79
Fairfield 60
Singapore 55
Ashburn 47
Seattle 31
Ann Arbor 28
Torino 25
Nyköping 24
Rome 20
Woodbridge 20
Houston 19
Jakarta 19
Turin 19
Cambridge 18
Princeton 16
Beijing 14
Wilmington 13
Medford 10
Boston 9
Redwood City 9
Dong Ket 8
Santa Clara 8
Hong Kong 7
Milan 7
Abuja 6
Guangzhou 6
Jacksonville 6
Nanjing 6
New York 6
Pisa 6
San Diego 6
Upper Marlboro 6
Boardman 5
Fremont 5
Genoa 4
Lappeenranta 4
Montréal 4
Paris 4
Riverton 4
Warsaw 4
Apodaca 3
Dearborn 3
Franklin 3
Hefei 3
Los Angeles 3
Naples 3
Prineville 3
San Jose 3
Seoul 3
Shanghai 3
Silver Spring 3
Tianjin 3
Toulouse 3
Turda 3
Avellino 2
Bothell 2
Brno 2
Brussels 2
Central District 2
Chengdu 2
Chicago 2
Coimbra 2
Dortmund 2
East Lansing 2
Edmonton 2
Fidenza 2
Florence 2
Harbin 2
Hebei 2
Kamiokubo 2
Lille 2
Madrid 2
Milwaukee 2
Montreal 2
Moscow 2
Pune 2
Raritan 2
Rochester 2
San Mateo 2
Split 2
St Louis 2
Sydney 2
Taipei 2
Villeurbanne 2
Wuhan 2
Amstelveen 1
Ankara 1
Antalya 1
Bangkok 1
Barendrecht 1
Basel 1
Berlin 1
Bolzano Vicentino 1
Breitenfelde 1
Bristol 1
Bucharest 1
Buenos Aires 1
Changchun 1
Changsha 1
Totale 940
Nome #
Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists 121
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience 114
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications 113
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature 112
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy 110
Role of cyclin-dependent kinase inhibitors in endometrial cancer 76
Role of Mediterranean diet in preventing platinum based gastrointestinal toxicity in gynecolocological malignancies: A single Institution experience 69
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers 61
Veliparib: a new therapeutic option in ovarian cancer? 56
The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality 55
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey 52
Biomarkers of central nervous system involvement from epithelial ovarian cancer 51
Immunotherapy for Cervical Cancer: Are We Ready for Prime Time? 47
Differences in parp inhibitors for the treatment of ovarian cancer: Mechanisms of action, pharmacology, safety, and efficacy 46
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 46
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis 45
Immunotherapy in cervix cancer 45
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22) 44
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study 29
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society 19
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study 14
Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case report 13
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial 13
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience 11
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors 9
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study 9
Totale 1.380
Categoria #
all - tutte 5.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.959


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 3 1 3 9 8 7 9 9 15
2020/2021219 5 26 50 19 13 21 10 14 3 18 5 35
2021/2022221 16 8 9 3 9 6 8 6 15 24 65 52
2022/2023453 39 56 12 41 48 102 22 27 50 7 27 22
2023/2024269 35 44 11 21 14 27 9 14 5 23 22 44
2024/2025110 11 43 38 18 0 0 0 0 0 0 0 0
Totale 1.380